BRC News


New findings on treating drug resistant HIV

Initial treatment for HIV is three times more likely to fail if a person is infected with transmitted drug resistant (TDR) HIV compared to non-resistant HIV, according to a European-wide study involving CBRC and UCL investigators.

UCLH/UCL CBRC investigators honoured in awards

CBRC investigator Professor Derek Yellon is one of 23 eminent researchers to be honoured with the status of National Institute of Health Research (NIHR) Senior Investigator in the latest round of NIHR appointments.